| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.3 | 0.006 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.092 | 0.006 |